These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 3037161)
1. Lowering of arterial blood pressure limits glomerular sclerosis in rats with renal ablation and in experimental diabetes. Zatz R; Anderson S; Meyer TW; Dunn BR; Rennke HG; Brenner BM Kidney Int Suppl; 1987 May; 20():S123-9. PubMed ID: 3037161 [No Abstract] [Full Text] [Related]
2. The role of intraglomerular pressure in the initiation and progression of renal disease. Anderson S; Brenner BM J Hypertens Suppl; 1986 Dec; 4(5):S236-8. PubMed ID: 3033176 [TBL] [Abstract][Full Text] [Related]
3. 11-Deoxycorticosterone-induced hypertension, glomerulosclerosis and renal arterial and arteriolar lesions. Shimamura T Jpn J Exp Med; 1988 Oct; 58(5):225-8. PubMed ID: 3244171 [TBL] [Abstract][Full Text] [Related]
5. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. Brenner BM; Meyer TW; Hostetter TH N Engl J Med; 1982 Sep; 307(11):652-9. PubMed ID: 7050706 [No Abstract] [Full Text] [Related]
6. Dietary protein and the progression of renal disease. Meyer TW; Lawrence WE; Brenner BM Kidney Int Suppl; 1983 Dec; 16():S243-7. PubMed ID: 6588259 [No Abstract] [Full Text] [Related]
7. Hypertension and glomerular sclerosis: where, when and how? el Nahas AM Contrib Nephrol; 1990; 78():61-70; discussion 70-2. PubMed ID: 2225844 [No Abstract] [Full Text] [Related]
8. [Prevention and countermeasures in kidney diseases complicated by hypertension]. Fujiwara Y; Takama T; Orita Y; Kamada T Nihon Rinsho; 1989 Sep; 47(9):2091-6. PubMed ID: 2593282 [No Abstract] [Full Text] [Related]
9. Glomerular cells in the progression of human and experimental nephropathies. Floege J; Gröne HJ Adv Nephrol Necker Hosp; 1997; 27():15-37. PubMed ID: 9408440 [No Abstract] [Full Text] [Related]
10. Antihypertensive therapy must control glomerular hypertension to limit glomerular injury. Anderson S; Rennke HG; Brenner BM J Hypertens Suppl; 1986 Dec; 4(5):S242-4. PubMed ID: 3553475 [TBL] [Abstract][Full Text] [Related]
11. [The importance of overweight and obesity for the development and progression of renal diseases]. Klassen A; Bahner U; Sebekova K; Heidland A Dtsch Med Wochenschr; 2004 Mar; 129(11):579-82. PubMed ID: 14997412 [No Abstract] [Full Text] [Related]
13. [Focal-segmental glomerulosclerosis in analgesic nephropathy]. Bürgin M; Schmidt M; Reutter F Schweiz Med Wochenschr; 1984 Aug; 114(33):1118-23. PubMed ID: 6484541 [TBL] [Abstract][Full Text] [Related]
14. Secondary focal and segmental glomerulosclerosis. Ferrario F; Rastaldi MP; Pasi A Nephrol Dial Transplant; 1999; 14 Suppl 3():58-67. PubMed ID: 10382984 [No Abstract] [Full Text] [Related]
15. [The effect of losartan on glomerular sclerosis in rats with diabetic nephropathy]. Xu JY; Tao LJ; Wang L; Ning WB; Liu JS Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 33(9):836-40. PubMed ID: 18812664 [TBL] [Abstract][Full Text] [Related]
19. Spontaneous hypertension and hypertensive renal disease in the fawn-hooded rat. Kuijpers MH; Gruys E Br J Exp Pathol; 1984 Apr; 65(2):181-90. PubMed ID: 6370289 [TBL] [Abstract][Full Text] [Related]
20. Analysis of renal structural and functional features in two rat strains with a different susceptibility to glomerular sclerosis. Grond J; Beukers JY; Schilthuis MS; Weening JJ; Elema JD Lab Invest; 1986 Jan; 54(1):77-83. PubMed ID: 3941543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]